Diagnosis and Clinical Management of Monogenic Diabetes
- PMID: 33180404
- Bookshelf ID: NBK563964
Diagnosis and Clinical Management of Monogenic Diabetes
Excerpt
Monogenic forms of diabetes are responsible for 1-3% of all young-onset diabetes. The multiple genes involved can cause one or both of the main phenotypes- congenital (neonatal) diabetes or MODY (maturity-onset diabetes of the young). The timely and accurate genetic diagnosis of monogenic diabetes provides an opportunity to target therapy to the underlying gene cause, refine management, and identify affected and at-risk relatives. As there is clinical overlap of monogenic diabetes with type 1 and type 2 diabetes, presenting clinical and laboratory features warrant careful attention to aid in diabetes classification and to identify those individuals who warrant genetic testing. These include those negative for islet cell autoantibodies with persistent c-peptide, suggesting a diagnosis other than type 1 diabetes. While obesity does not preclude monogenic diabetes, certainly individuals lacking obesity and other features of metabolic disease should be referred for diagnostic genetic testing. Understanding who and how to refer for genetic testing and how to interpret test results is key to precision medicine in diabetes. The most common forms of monogenic diabetes have specific therapies and management strategies that can optimize glycemic control and minimize complications resulting in improved health outcomes for affected individuals. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text,
Copyright © 2000-2025, MDText.com, Inc.
Sections
- ABSTRACT
- INTRODUCTION
- WHY SHOULD YOU DO GENETIC TESTING FOR MONOGENIC DIABETES?
- HOW SHOULD GENETIC TESTING FOR MONOGENIC DIABETES BE CARRIED OUT?
- HOW SHOULD GENETIC TESTING RESULTS BE INTERPRETED?
- WHO SHOULD YOU TEST FOR MONOGENIC DIABETES?
- HOW SHOULD YOU MANAGE SPECIFIC SUBTYPES OF MONOGENIC DIABETES?
- ADDITIONAL BENEFITS OF ACCURATE MONOGENIC DIABETES DIAGNOSIS
- CONCLUSIONS
- REFERENCES
References
-
- Kanakatti Shankar R, Pihoker C, Dolan LM, Standiford D, Badaru A, Dabelea D, Rodriguez B, Black MH, Imperatore G, Hattersley A, Ellard S, Gilliam LK, SEARCH for Diabetes in Youth Study Group Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. 2013;14(3):174–180. doi: 10.1111/pedi.12003. - DOI - PMC - PubMed
-
- Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, Oram RA, Knight B, Hyde C, Cox J, Mallam K, Moudiotis C, Smith R, Fraser B, Robertson S, Greene S, Ellard S, Pearson ER, Hattersley AT. UNITED Team. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016;39(11):1879–1888. doi: 10.2337/dc16-0645. - DOI - PMC - PubMed
-
- Shields BM, Shepherd M, Hudson M, McDonald TJ, Colclough K, Peters J, Knight B, Hyde C, Ellard S, Pearson ER, Hattersley AT. team OBOTUS. Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients. Diabetes Care. 2017;40(8):dc170224–1025. doi: 10.2337/dc17-0224. - DOI - PMC - PubMed
-
- Johnson SR, Carter HE, Leo P, Hollingworth SA, Davis EA, Jones TW, Conwell LS, Harris M, Brown MA, Graves N, Duncan EL. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care. 2018:dc180261. doi: 10.2337/dc18-0261. - DOI - PubMed